retatrutide phase 2 weight loss is generating a lot of buzz in the medical world—and for good reason. As research continues, many experts believe it could represent the next generation of metabolic health treatments Retatrutide Shows Strong Weight Loss

52,53 In a phase 2, multi-center trial conducted at 45 centers, orforglipron at doses of 12 mg or greater showed significant reductions in HbA1c and bodyweight compared with placebo or dulaglutide

The letter was part of a broader March 2026 FDA sweep that named more than 30 telehealth companies over compounded GLP-1 marketing practices, so this was an industry-wide compliance issue rather than an isolated scandal

A short-form complaint will lead to increased filings in the Ozempic lawsuit

Matt Kaeberlein In the final episode of our three-part series on longevity, we had the pleasure of speaking with Dr

Med (Baltimore)